AB Science announces that masitinib study in primary and secondary progressive forms of multiple sclerosis has passed its non-futility test at 2 years The study has completed patient recruitment ...

FIRST ON FOX: A prominent left-wing dark money nonprofit poured nearly $150 million in secret cash into progressive groups and causes in 2022, tax forms obtained by Fox News Digital show. The Sixteen ...

The role of imaging in diagnosing progressive multiple sclerosis (MS) and in assessing prognosis is the subject of a new review. MRI is central in the diagnostic workup of patients suspected of having ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

New MS treatments target myelin repair, neuroprotection, and CNS-resident immune cells, offering hope for progressive forms of the disease. Bruton tyrosine kinase inhibitors (BTKis) like tolebrutinib ...

Based on promising results from the Phase 1a study including sustained disability improvements among progressive MS patients, the Phase 1b study will assess clinical outcomes including measures of ...

– Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) ...

Linguists and grammarians have labeled this structure as the am-Progressive or die Verlaufsform in the German literature. Until this point, there has been consensus that the form represents an ...

As third-party cookies come to an end, brands are focusing on collecting more zero-party data directly from their customers and prospects so they can better understand their needs and wants. Although ...